From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.

I have been very fortunate to have had a varied and diverse career accelerating the development of life science innovation, including therapeutics, vaccines, medical devices, diagnostics, analytical instruments,...

Cellia Science Awarded National Institutes of Health Phase I SBIR Funding

Fayetteville, AR - Cellia Science, a point-of-care hematology company, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Heart, Lung, and Blood...

VIC Fellows Spotlight: Matthew Leming, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

VIC 2022 Annual Report Executive Summary

2022 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.

VIC Tech Adds Chantell Preston to Board of Directors

Bringing a proven track record in healthcare operations, innovation, and investing. FAYETTEVILLE, AR- VIC Technology Venture Development is pleased to announce the appointment of Chantell Preston, who brings 20+ years...

A Letter from our CEO

As CEO of VIC Tech, I am fortunate to have the opportunity to review exciting new life science technologies on an ongoing basis and regularly speak with life science thought leaders, inventors, investors, and large...

FEATURED RESOURCES

Updates
VIC Tech Continues to Grow Its Medical Advisory Board
Insight
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside CTTC at Vanderbilt University with Assistant Director, Physical Sciences Ashok Choudhury
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Cellia Science Formed to Develop and Commercialization Point-of-Care Hematology Analyzers
Interview
VIC Fellows Spotlight: Alexandra Antonioli, MD, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission